![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C12N 9/22 | (2006.01) |
C12N 15/63 | (2006.01) | ||
C12N 5/0783 | (2010.01) | ||
A61P 35/00 | (2006.01) |
(11) | Patento numeris | 3309248 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17183472.4 |
Europos patento paraiškos padavimo data | 2014-04-01 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-04-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-09 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201370297 | 2013-05-29 | DK | |
201361888259 P | 2013-10-08 | US | |
201361907858 P | 2013-11-22 | US | |
201361907874 P | 2013-11-22 | US | |
201370771 | 2013-12-13 | DK | |
PCT/EP2014/051458 | 2014-01-24 | WO |
(72) |
DUCHATEAU, Philippe , FR
CHOULIKA, André , FR
POIROT, Laurent , FR
|
(73) |
Cellectis ,
8 rue de la Croix Jarry, 75013 Paris,
FR
|
(54) | METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM |
METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM |